LIPT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.728200E-01
Normal-vs-Stage2
3.033600E-01
Normal-vs-Stage3
1.297390E-01
Normal-vs-Stage4
4.470600E-01
Stage1-vs-Stage2
1.563350E-01
Stage1-vs-Stage3
1.106400E-01
Stage1-vs-Stage4
7.983000E-01
Stage2-vs-Stage3
3.625400E-01
Stage2-vs-Stage4
1.438630E-01
Stage3-vs-Stage4
1.402770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.089600E-01
Normal-vs-AfricanAmerican
2.775000E-01
Normal-vs-Asian
8.390100E-02
Caucasian-vs-AfricanAmerican
6.649800E-01
Caucasian-vs-Asian
9.957400E-01
AfricanAmerican-vs-Asian
7.315200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.050000E-01
Normal-vs-Female
3.090000E-01
Male-vs-Female
9.075400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.569600E-01
Normal-vs-Age(41-60Yrs)
3.183800E-01
Normal-vs-Age(61-80Yrs)
3.060600E-01
Normal-vs-Age(81-100Yrs)
2.824000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.482200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.523600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.705200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.446200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.032400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.550000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.127910E-02
Normal-vs-Daily Drinker
2.707200E-01
Normal-vs-Weekly Drinker
4.226300E-02
Normal-vs-Occasional Drinker
3.661200E-01
Normal-vs-Social Drinker
5.854100E-02
Non Drinker-vs-Daily Drinker
9.901800E-01
Non Drinker-vs-Weekly Drinker
6.262600E-01
Non Drinker-vs-Occasional Drinker
1.168240E-01
Non Drinker-vs-Social Drinker
3.827400E-01
Daily Drinker-vs-Weekly Drinker
6.384000E-01
Daily Drinker-vs-Occasional Drinker
1.182960E-01
Daily Drinker-vs-Social Drinker
3.984200E-01
Weekly Drinker-vs-Occasional Drinker
3.580800E-01
Weekly Drinker-vs-Social Drinker
7.390800E-01
Occasional Drinker-vs-Social Drinker
6.200600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.735900E-02
Normal-vs-Grade 2
9.716400E-03
Normal-vs-Grade 3
6.316000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.036800E-01
Grade 1-vs-Grade 3
4.250000E-01
Grade 1-vs-Grade 4
6.735900E-02
Grade 2-vs-Grade 3
5.658000E-01
Grade 2-vs-Grade 4
9.716400E-03
Grade 3-vs-Grade 4
6.316000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.742400E-01
Normal-vs-NonDiabetic
2.905600E-01
Diabetic-vs-NonDiabetic
5.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.844500E-02
Normal-vs-NoPancreatitis
2.879800E-01
Pancreatitis-vs-NoPancreatitis
7.677400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.222200E-02
Normal-vs-N1
2.911200E-01
N0-vs-N1
1.115050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.016800E-01
Normal-vs-TP53-NonMutant
4.542800E-01
TP53-Mutant-vs-TP53-NonMutant
3.822200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
